Stem cell and bone marrow transplants are now regularly used as curative treatments for patients with blood cancer (such as lymphoma, myeloma and leukaemia). Yet 4 in 5 patients from black, Asian, mixed-heritage or other minority ethnic groups are unable to find a donor match.
Race Against Blood Cancer works to increase the total number of people on the stem cell and bone marrow register, with a particular emphasis on increasing the level of sign up from minority groups – whether defined by race, ethnicity or gender – who are vastly underrepresented on the donor registry at present. Our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match.
We have a simple overarching strategy to deliver on our vision:
1. Raise awareness of the underrepresentation issue and improve apathy;
2. Educate people on the process of becoming a donor and demystifying the many myths that currently exist; and
3. Help simplify the donor sign up process, making it more accessible for everyone.
The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the financial year 1st April 2021 to 31st March 2022. Having seen the challenges for previous reporting periods prove more difficult due to the worldwide Covid-19 pandemic, 2022 has seen an uplift in activity and our in-person donor drives are now back on track. However, we are still reeling from the significant impact Covid has had in terms of our donor engagement potential.
As a result of our efforts in previous years, some of our potential stem cell donors continued to be matched to patients in need, with the charity now responsible for 16 stem cell transplants from the pool of nearly 10,000 donors that we have recruited.
## **Employees**
General Manager Nicola Martenstyn
Nicola is supported by a number of committed Community Engagement individuals who work for the charity on a freelance basis; Gemma Elsmore, for West Midlands and Alex Morrison for London. We no longer have our Communications Officer Tess Suleman. Funding for a full-time Community Engagement Manager was secured in in 2021/22 and Gemma Elsmore was appointed to this role, commencing her employment in April 2022.
Race Against Blood Cancer is a registered charity number 1162696 Registered office address: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ
Both the General Manager and Community Engagement Manager roles have been made possible by receiving appropriate funding and they will continue to work towards increasing donor recruitment activities as a priority for re-establishing our engagement and growth.
In addition to our paid staff, we are ably supported by a number of volunteers who assist with our finance administration and donor recruitment events. Our grateful thanks must go to this group for their commitment to the charity; they are instrumental to our current and future success and have remained steadfast in terms of their support.
## **Achievements and performance**
## **Donor recruitment**
Due to the pandemic, all face to face donor recruitment events stopped for a substantial amount of time. However, we were able to continue recruitment online with our existing registry partner, DKMS, as well as setting up a new partnership with Anthony Nolan in order to share patient stories with a view to recruiting to their register.
With our newly appointed Community Engagement Manager in place for next year, our aim is to reengage with the general public in a face-to-face capacity in order to recruit new people onto the donor register. We have continued to work closely with our partners, DKMS and Anthony Nolan, to ensure that the general public have the best engagement with us as possible whilst maintaining clarity that the information we share is specific to our partner agencies and thus relevant to our purpose. Our in-person donor drives have been severely limited due to the after effect of the pandemic but we have continued to work alongside our partners in order to harness as much support as possible with the view and focus to recruit more diverse people onto donor registries.
The pandemic has also had an impact on our ability to carry out fundraising events. We have reengaged with Wolves Football Club with the view that work will be undertaken to re-install events. However, we envisage more work to be done with regards to our digital engagement and to increase awareness through online mediums. Over the last year, we continued to share case studies of those affected by blood cancer in order to share real-life stories and keep the momentum going.
We have been developing relationships and growing our network within the industry. As a direct result of this work, the charity continues to be a member of the NBTA (National BAME Transplant Alliance) sub-committee on stem cell donation. This group, which consists of a number of charities as well as all four UK donor registries, expects to have a significant role in developing a national donor recruitment strategy for people from black, Asian, mixed-heritage and minority ethnic communities over the next few years.
## **Fundraising**
The landscape for fundraising is still a challenging environment and some work has been undertaken to try and secure funding via the Trusts & Grants route. The highly anticipated cycle event with Carl Ikeme and Joleon Lescott was postponed several times due to Covid-19 restrictions. We are working with Wolves FC to ascertain what other event we can have in place for 2022/23 in order that we can bridge the gap in terms of harnessing fresh support.
The charity was fortunate to benefit from a £20,000 grant from The People’s Postcode Trust towards the West Midlands Community Engagement pilot project. This project will commence in April 2022 with the successful and confirmed recruitment of Gemma Elsmore.
We also received confirmation in January 2022 for Postcode Lottery funding that will allow us to develop our website – with the vision that our online profile becomes more integrated in supporting agencies work, allowing us to capture supporter data and to strengthen our brand awareness as a whole. We will be working towards tendering this work out to appropriate website developers and it is anticipated that this work will commence in 2022/23.
## **Collaboration and strategic impact**
Through the NBTA and close collaboration with other small charities, we have seen the Aligned Registry (AN, DKMS, WBMDR and NHSBT) increase their ethnic minority donor targets and enhance their contractual alignment into 2022 and beyond. We have established an ongoing series of meetings with the Aligned Registry, with the goal of collaborating more closely, and taking more responsibility for ethnic minority recruitment.
## **Acknowledgements**
The Trustees would like to thank the following individuals, companies and charitable trusts and organisations for their support throughout 2021/22:
Anthony Nolan DKMS UK
The People’s Postcode Trust
Wolverhampton Wanderers FC
## ACLT
Sue Harris Trust
Team Margot
10,000 Donors
## **Race Against Blood Cancer**
**Charity No. 1162696**
**Company No. CE005053**
**Trustees' Report and Unaudited Accounts**
**31 March 2022**
**Race Against Blood Cancer Contents**
||Pages||
|---|---|---|
|Trustees' Annual Report||2|
|Independent Examiner's Report||3|
|Statement of Financial Activities||4|
|Summary Income and Expenditure Account||5|
|Balance Sheet||6|
|Statement of Cash flows||7|
|Notes to the Accounts|8 to|14|
|Detailed Statement of Financial Activities|15 to|16|
Page 1
**Race Against Blood Cancer Trustees Annual Report**
The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2022.
## **REFERENCE AND ADMINISTRATIVE DETAILS**
## **Company No. CE005053**
## **Charity No. 1162696**
## **Registered Office**
71-75 Shelton Street Covent Garden London WC2H 9JQ
## **Directors and Trustees**
The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year:
J. Bates G. Fiske D. Gardner M.M. Gardner J.I.B. Knox-Hooke H. Shah B. Westwood
## **Accountants**
Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).
Signed on behalf of the board
## Joe Bates
Joe Bates (Dec 12, 2022 11:17 GMT) J. Bates Trustee 23 November 2022
Page 2
**Race Against Blood Cancer Independent Examiners Report**
## **Independent Examiner's Report to the trustees of Race Against Blood Cancer**
I report to the charity trustees on my examination of the financial statements of Race Against Blood Cancer for the year ended 31 March 2022 which comprise the Statement of Financial Activities, the Summary Income and Expenditure Account, the Balance Sheet, the Statement of Cash Flows and the related notes.
## **Responsibilities and basis of report**
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act.
Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that:
- accounting records were not kept in accordance with section 386 of the 2006 Act ; or
- the financial statements do not accord with those records; or
- the financial statements do not comply with the accounting requirements under section 396 of the 2006 Act other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination; or
- the financial statements have not been prepared in accordance with the Charities SORP (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield
HD1 5JL 23 November 2022
Page 3
**Race Against Blood Cancer Statement of Financial Activities**
## **for the year ended 31 March 2022**
|**Notes**
**Income and endowments**
**from:**
Donations and legacies
4
Other
5
**Total**
**Expenditure on:**
Raising funds
6
Other
7
**Total**
Net gains on investments
**Net (expenditure)/income**
8
Transfers between funds
**Net (expenditure)/income**
**before other gains/(losses)**
**Other gains and losses**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|**Unrestricted**
**funds**
**2022**
**£**
12,505
9,412|**Restricted**
**funds**
**2022**
**£**
-
-|**Total funds**
**2022**
**£**
12,505
9,412|**Total funds**
**2021**
**£**
38,828
16,341|
|---|---|---|---|---|
||21,917
1,209
25,410|-
-
-|21,917
1,209
25,410|55,169
2,016
32,366|
||26,619
-|-
-|26,619
-|34,382
-|
||(4,702)
-|-
-|(4,702)
-|20,787
-|
||(4,702)|-|(4,702)|20,787|
||(4,702)
13,313|-
38,015|(4,702)
51,328|20,787
12,526|
||8,611|38,015|46,626|33,313|
Page 4
**Race Against Blood Cancer Summary Income and Expenditure Account**
## **for the year ended 31 March 2022**
|Income
**Gross income for the year**
Expenditure
Interest payable
**Total expenditure for the year**
Net (expenditure)/income before tax
for the year
**Net (expenditure )/income for the year**|**2022**
**£**
21,917
21,917
26,392
227
26,619
(4,702)
(4,702)|**2021**
**£**
55,169|
|---|---|---|
|||55,169|
|||34,382
-|
|||34,382|
|||20,787|
|||20,787|
Page 5
**Race Against Blood Cancer Balance Sheet**
## **at 31 March 2022**
|**Company No.**
**CE005053**
**Notes**
**2022**
**£**
**Current assets**
Cash at bank and in hand
60,219
60,219
**Creditors:**Amount falling due within one year
10
(3,495)
**Net current assets**
56,724
**Total assets less current liabilities**
56,724
**Creditors:**Amounts falling due after more than one year
11
(10,098)
**Net assets excluding pension asset or liability**
46,626
**Total net assets**
46,626
**The funds of the charity**
**Restricted funds**
12
Restricted income funds
38,015
38,015
**Unrestricted funds**
12
General funds
8,611
8,611
**Reserves**
12
**Total funds**
46,626|**2021**
**£**
65,253|
|---|---|
||65,253
(1,925)|
||63,328
63,328
(12,000)|
||51,328|
||51,328|
||38,015|
||38,015
13,313|
||13,313|
||51,328|
These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.
For the year ended 31 March 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
Approved by the board on 23 November 2022
And signed on its behalf by:
## Joe Bates
Joe Bates (Dec 12, 2022 11:17 GMT)
J. Bates
Trustee
23 November 2022
Page 6
**Race Against Blood Cancer Statement of Cash flows for the year ended 31 March 2022**
|**Cash flows from operating activities**
**Net (expenditure)/income per Statement of Financial Activities**
**Adjustments for:**
Dividends, interest and rents from investments
Increase/(Decrease) in trade and other payables
**Net cash (used in)/provided by operating activities**
**Cash flows from investing activities**
Dividends, interest and rents from investments
**Net cash from investing activities**
**Cash flows from financing activities**
Repayment of borrowings
**Net cash (used in)/from financing activities**
**Net (decrease)/increase in cash and cash equivalents**
**Cash and cash equivalents at the beginning of the year**
**Cash and cash equivalents at the end of the year**
**Components of cash and cash equivalents**
Cash and bank balances|**2022**
**£**
(4,702)
(9,412)
1,570
(12,544)
9,412
9,412
(1,902)
(1,902)
(5,034)
65,253
60,219
60,219
60,219|**2021**
**£**
38,802
(16,341)
(2,018)|
|---|---|---|
|||2,428
16,341|
|||16,341|
|||15,000|
|||15,000|
||||
|||33,769|
|||31,484|
|||65,253|
||||
|||65,253|
||||
|||65,253|
Page 7
**Race Against Blood Cancer Notes to the Accounts**
## **for the year ended 31 March 2022**
- 1 **Accounting policies**
## **Basis of preparation**
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
## **Change in basis of accounting or to previous accounts**
There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.
## **Fund accounting**
- Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity.
- Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Revaluation funds These are unrestricted funds which include a revaluation reserve representing the restatement of investment assets at their market values.
- Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal.
## **Income**
- Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability.
- Income with related Where income has related expenditure the income and related expenditure is expenditure reported gross in the SoFA. Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income.
- Tax reclaims on Income from tax reclaims is included in the SoFA at the same time as the donations and gifts gift/donation to which it relates. Donated services These are only included in income (with an equivalent amount in expenditure) and facilities where the benefit to the Charity is reasonably quantifiable, measurable and material.
Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets
Page 8
**Race Against Blood Cancer Notes to the Accounts**
## **Expenditure**
- Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates.
- Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs.
- Grants payable All grant expenditure is accounted for on an actual paid basis plus an accrual for grants that have been approved by the trustees at the end of the year but not yet paid.
- Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs.
- Other expenditure These are support costs not allocated to a particular activity.
## **Taxation**
The charity is exempt from corporation tax on its charitable activities.
## **Freehold investment property**
Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.
## **Stocks**
Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.
## **Trade and other debtors**
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.
## **Trade and other creditors**
Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Page 9
**Race Against Blood Cancer Notes to the Accounts**
## **Research and development**
Expenditure on research and development is written off in the year in which it is incurred.
## **Foreign currencies**
Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period.
Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred.
All exchange differences are are taken into account in arriving at net income/expenditure.
## **Leased assets**
Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.
Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.
Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs.
Assets held under finance leases are depreciated in the same way as owned assets.
Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.
## **Pension costs**
The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
## **Receipt of donated goods, facilities and services**
All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.
## 2 **Company status**
The company is a private company limited by guarantee and consequently does not have share capital.
Page 10
**Race Against Blood Cancer Notes to the Accounts**
3 **Statement of Financial Activities - prior year**
|**Income and endowments from:**
Donations and legacies
Other
**Total**
**Expenditure on:**
Raising funds
Other
**Total**
**Net income**
Transfers between funds
**Net income before other**
**gains/(losses)**
**Other gains and losses:**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
4
**Income from donations and legacies**
Adhoc Donations MyDonate
Donations From Events
General Donations
Regular Donations
5
**Other income**
Government JRS Grant|**Unrestricted**
**funds**
**2021**
**£**
18,828
16,341
35,169
2,016
32,366
34,382
787
18,015
18,802
18,802
(5,489)
13,313
**Unrestricted**
**£**
-
8,652
3,793
60
12,505
**Unrestricted**
**£**
9,412
9,412|**Restricted**
**funds**
**2021**
**£**
20,000
-
20,000
-
-
-
20,000
-
20,000
20,000
18,015
38,015
**Total**
**2022**
**£**
-
8,652
3,793
60
12,505
**Total**
**2022**
**£**
9,412
9,412|**Total funds**
**2021**
**£**
38,828
16,341|
|---|---|---|---|
||||55,169
2,016
32,366|
||||34,382|
||||20,787
18,015|
||||38,802|
||||38,802
12,526|
||||51,328|
||||**Total**
**2021**
**£**
1
10,463
28,212
152|
||||38,828|
||||**Total**
**2021**
**£**
16,341|
||||16,341|
Page 11
**Race Against Blood Cancer Notes to the Accounts**
|6
**Expenditure on raising funds**
_Costs of generating voluntary_
_income_
Adhoc Donations MyDonate
Donations From Events
7
**Other expenditure**
Bank loan and overdraft
interest payable
Employee costs
General administrative costs
Legal and professional costs
8
**Net (expenditure)/income before transfers**
This is stated after charging:
Independent Examiner's fee
Other fees paid to the auditor or
independent examiner
9
**Staff costs**
Salaries and wages
Social security costs
Pension costs
No employee received emoluments in excess of £60,000.
10 **Creditors:**
amounts falling due within one year
Bank loans and overdrafts
Other taxes and social security
Other creditors|**Unrestricted**
**£**
388
821
1,209
**Unrestricted**
**£**
227
21,798
2,027
1,358
25,410
**2022**
**£**
650
180
**2022**
25,153
(3,873)
518
21,798
**2022**
**£**
3,000
495
-
3,495|**Total**
**2022**
**£**
388
821
1,209
**Total**
**2022**
**£**
227
21,798
2,027
1,358
25,410|**Total**
**2021**
**£**
1,457
559|
|---|---|---|---|
||||2,016|
||||**Total**
**2021**
**£**
-
26,517
2,544
3,305|
||||32,366|
||||**2021**
**£**
650
-
**2021**
25,924
-
593|
||||26,517|
||||**2021**
**£**
3,000
(1,206)
131|
||||1,925|
Page 12
**Race Against Blood Cancer Notes to the Accounts**
## 11 **Creditors:**
amounts falling due after more than one
year
|Bank loans and overdrafts
12 **Movement in funds**
**Restricted funds:**
**Restricted income funds:**
Aylesford Family Trust
Roger Counter Foundation
W E Dunn Trust None
Albert Hunt Trust
Alex Duthie
Help Charity Shop
Christmas appeal
The People's Postcode Trust
_Total_
**Unrestricted funds:**
**General funds**
**Total funds**|**At 1 April**
**2021**
500
15,000
1,000
1,000
210
200
105
20,000
38,015
13,313
51,328|**2022**
**£**
10,098
10,098
**Incoming**
**resources**
**(including**
**other**
**gains/losses)**
**£**
-
-
-
-
-
-
-
-
-
21,917
21,917|**Resources**
**expended**
**£**
-
-
-
-
-
-
-
-
-
(26,619)
(26,619)|**2021**
**£**
12,000|
|---|---|---|---|---|
|||||12,000|
|||||**At 31**
**March**
**2022**
**£**
500
15,000
1,000
1,000
210
200
105
20,000|
|||||38,015|
|||||8,611|
|||||46,626|
Purposes and restrictions in relation to the funds: Restricted funds: Aylesford Family Trust Roger Counter Foundation W E Dunn Trust None Albert Hunt Trust Alex Duthie Help Charity Shop Christmas appeal The People's Postcode Trust
Page 13
**Race Against Blood Cancer Notes to the Accounts**
## 13 **Analysis of net assets between funds**
|Net current assets
Creditors due in more than one year and
provisions
14 **Reconciliation of net debt**
Cash and cash equivalents
Bank loans
Net debt|**At 1 April**
**2021**
**£**|**Unrestricted**
**funds**
**£**
56,724
(10,098)
46,626
**Cash flows**
**£**|**Total**
**£**
56,724
(10,098)|
|---|---|---|---|
||||46,626|
||||**At 31**
**March**
**2022**
**£**|
||65,253|(5,034)|60,219|
||65,253
(15,000)
(15,000)
50,253|(5,034)
1,902
1,902
(3,132)|60,219
(13,098)|
||||(13,098)|
||||47,121|
|||||
|15 **Commitments**
**_Operating lease commitments_**
Annual commitments under non-cancellable operating leases are as follows:
**2022**
**2022**
**Land and**
**buildings**
**Other**
**£**
**£**
Operating leases with expiry date:
**_Pension commitments_**
**2022**
**£**
The pension cost charge to the company
amounted to:
518||**2021**
**Land and**
**buildings**
**£**|**2021**
**Other**
**£**
**2021**
**£**
593|
## 16 **Related party disclosures**
## _**Controlling party**_
The company is limited by guarantee and has no share capital; thus no single party controls the company.
Page 14
**Race Against Blood Cancer Detailed Statement of Financial Activities**
## **for the year ended 31 March 2022**
|**Income and endowments from:**
Donations and legacies
Adhoc Donations MyDonate
Donations From Events
General Donations
Regular Donations
Other
Government JRS Grant
**Total income and endowments**
**Expenditure on:**
Costs of generating donations and
legacies
Adhoc Donations MyDonate
Donations From Events
**Total of expenditure on raising**
**funds**
Other expenditure
Bank loan and overdraft interest
payable
Employee costs
Salaries/wages
Employer's NIC
Pension costs
General administrative costs,
including depreciation and
amortisation
General insurances
Postage and couriers
Software, IT support and related
costs
Stationery and printing
Sundry expenses
Telephone, fax and broadband|**Unrestricted**
**funds**
**2022**
**£**
-
8,652
3,793
60
12,505
9,412
9,412
21,917
388
821
1,209
1,209
227
227
25,153
(3,873)
518
21,798
324
-
360
139
886
318
2,027|**2022**
**£**
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-|**Total funds**
**2022**
**£**
-
8,652
3,793
60
12,505
9,412
9,412
21,917
388
821
1,209
1,209
227
227
25,153
(3,873)
518
21,798
324
-
360
139
886
318
2,027|**Total funds**
**2021**
**£**
1
10,463
28,212
152|
|---|---|---|---|---|
|||||38,828|
|||||16,341|
|||||16,341|
|||||55,169
1,457
559|
|||||2,016|
|||||2,016
-|
|||||-|
|||||25,924
-
593|
|||||26,517|
|||||482
278
441
-
977
366|
|||||2,544|
Page 15
## **Race Against Blood Cancer Detailed Statement of Financial Activities**
|**Race Against Blood Cancer**
**Detailed Statement of Financial Activities**|||||
|---|---|---|---|---|
|Legal and professional costs
Accountancy and bookkeeping
Consultancy fees
**Total of expenditure of other costs**
**Total expenditure**
Net gains on investments
**Net (expenditure)/income**
Transfers between funds
**Net (expenditure)/income before**
**other gains/(losses)**
Other Gains
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|830
528
1,358
25,410
26,619
-
(4,702)
-
(4,702)
-
(4,702)
13,313
8,611|-
-
-
-
-
-
-
-
-
-
-
38,015
38,015|830
528
1,358
25,410
26,619
-
(4,702)
-
(4,702)
-
(4,702)
51,328
46,626|700
2,605|
|||||3,305|
||||||
|||||32,366|
|||||34,382
-|
|||||20,787
18,015|
|||||38,802
-|
|||||38,802|
|||||12,526|
|||||51,328|
Page 16